Kodiak Sciences (KOD) Interest Coverage Ratio (2017 - 2026)
Kodiak Sciences (KOD) posted Interest Coverage Ratio of 0.13 for Q1 2026, up 26.45% on a QoQ basis from 0.18 in Q4 2025, and up 99.59% year-over-year from 0.06 in Q1 2025.
Kodiak Sciences (KOD) Interest Coverage Ratio (2017 - 2026) Analysis & Trends
Kodiak Sciences' Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 0.13 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 99.59% year-over-year to 0.13 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.51 (up 99.52% YoY) and the FY2025 annual result came in at 0.71, up 5.53% from the prior year.
- Interest Coverage Ratio was 0.13 for Q1 2026 at Kodiak Sciences, up from 0.18 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.13 in Q1 2026 and bottomed at 18516.5 in Q4 2022.
- A 5-year average of 1121.25 and a median of 21.29 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio sank 17227.6% — and 2025, when it surged 99.66%.
- Kodiak Sciences' Interest Coverage Ratio stood at 18516.5 in 2022, then soared by 99.61% to 71.45 in 2023, then gained by 28.19% to 51.31 in 2024, then jumped by 99.66% to 0.18 in 2025, then grew by 26.45% to 0.13 in 2026.
- Business Quant data shows KOD's Interest Coverage Ratio at 0.13 in Q1 2026, 0.18 in Q4 2025, and 0.37 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | -0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.13 |
| Dec 31, 2025 | -0.18 |
| Sep 30, 2025 | -0.37 |
| Jun 30, 2025 | -9.61 |
| Mar 31, 2025 | -31.14 |
| Dec 31, 2024 | -51.31 |
| Sep 30, 2024 | -39.19 |
| Jun 30, 2024 | -80.78 |
| Mar 31, 2024 | -22.25 |
| Dec 31, 2023 | -71.45 |
| Sep 30, 2023 | -159.36 |
| Jun 30, 2023 | -16.89 |
| Mar 31, 2023 | -21.29 |
| Dec 31, 2022 | -18,516.50 |
| Sep 30, 2022 | -11.97 |
| Jun 30, 2022 | -14.29 |
| Mar 31, 2022 | -14.57 |
| Dec 31, 2021 | -18,609.80 |
| Sep 30, 2021 | -0.16 |
| Jun 30, 2021 | -0.13 |